BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1063571)

  • 1. Relationship between intracellular dihydrofolate reductase and tightly bound intracellular methotrexate in human neoplastic cells.
    Bender RA; Makulu DR
    Biochem Pharmacol; 1976 Apr; 25(8):975-6. PubMed ID: 1063571
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect and istribution of methotrexate in the human organism during leukemia treatment].
    Wilmanns W; Martin H
    Klin Wochenschr; 1968 Mar; 46(6):281-96. PubMed ID: 5245556
    [No Abstract]   [Full Text] [Related]  

  • 3. Differences in folylpolyglutamate synthetase and dihydrofolate reductase expression in human B-lineage versus T-lineage leukemic lymphoblasts: mechanisms for lineage differences in methotrexate polyglutamylation and cytotoxicity.
    Galpin AJ; Schuetz JD; Masson E; Yanishevski Y; Synold TW; Barredo JC; Pui CH; Relling MV; Evans WE
    Mol Pharmacol; 1997 Jul; 52(1):155-63. PubMed ID: 9224825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increase of dihydrofolate reductase activity in cultured mammalian cells after exposure to methotrexate.
    Hillcoat BL; Swett V; Bertino JR
    Proc Natl Acad Sci U S A; 1967 Oct; 58(4):1632-7. PubMed ID: 4230391
    [No Abstract]   [Full Text] [Related]  

  • 5. A nonfunctional protein in human leukemia cells reacts with antiserum to dihydrofolate reductase from L1210 leukemia cells.
    Iqbal MP; Rothenberg SP
    Life Sci; 1981 Aug; 29(7):689-96. PubMed ID: 6168882
    [No Abstract]   [Full Text] [Related]  

  • 6. Evidence for two molecular species of dihydrofolate reductase in amethopterin resistant and sensitive cells of the mouse leukemia L4946.
    Blumenthal G; Greenberg DM
    Oncology; 1970; 24(3):223-9. PubMed ID: 5418574
    [No Abstract]   [Full Text] [Related]  

  • 7. Human leukemia and normal leukocytes contain a species of immunoreactive but nonfunctional dihydrofolate reductase.
    Rothenberg SP; Iqbal MP
    Proc Natl Acad Sci U S A; 1982 Jan; 79(2):645-9. PubMed ID: 6952216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quinazoline antifolates as inhibitors of dihydrofolate reductase from human leukemia cells.
    Johns DG; Capizzi RL; Nahas A; Cashmore AR; Bertino JR
    Biochem Pharmacol; 1970 Apr; 19(4):1528-33. PubMed ID: 5284463
    [No Abstract]   [Full Text] [Related]  

  • 9. Dihydrofolic reductase in human blood cells. II. Enzyme activity after amethopterin and actinomycin C administration.
    Grignani F; Martelli MF; Tonato M
    Enzymol Biol Clin (Basel); 1967; 8(5):363-78. PubMed ID: 4168879
    [No Abstract]   [Full Text] [Related]  

  • 10. A new form of dihydrofolate reductase in cancer cells.
    Iqbal MP; Rothenberg SP
    J Pak Med Assoc; 1985 Aug; 35(8):237-42. PubMed ID: 3932700
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects on dihydrofolate reductase of methotrexate metabolites and intracellular folates formed following methotrexate exposure of human breast cancer cells.
    Drake JC; Allegra CJ; Baram J; Kaufman BT; Chabner BA
    Biochem Pharmacol; 1987 Jul; 36(14):2416-8. PubMed ID: 2440441
    [No Abstract]   [Full Text] [Related]  

  • 12. Dihydrofolate reductase activity and deoxynucleoside incorporation into DNA of human leukocytes. Relation to methotrexate administration.
    Roberts D; Hall TC
    Cancer; 1967 May; 20(5):905-10. PubMed ID: 5229019
    [No Abstract]   [Full Text] [Related]  

  • 13. Utilization of an immunostaining technique to demonstrate heterogeneity in the content of dihydrofolate reductase in peripheral blast cells from a patient with acute lymphocytic leukemia.
    Grill SP; Wells RJ; Cheng YC
    Cancer Res; 1984 Mar; 44(3):1252-6. PubMed ID: 6581868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evolution of methotrexate resistance of human acute lymphoblastic leukemia cells in vitro.
    Ohnuma T; Lo RJ; Scanlon KJ; Kamen BA; Ohnoshi T; Wolman SR; Holland JF
    Cancer Res; 1985 Apr; 45(4):1815-22. PubMed ID: 3856477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of transfer RNA methylase activity with growth and differentiation in normal and neoplastic tissues.
    Riddick DH; Gallo RC
    Cancer Res; 1970 Oct; 30(10):2484-92. PubMed ID: 4919822
    [No Abstract]   [Full Text] [Related]  

  • 16. 7,8-Dihydropteroyl oligo-gamma-L-glutamates: synthesis and kinetic studies with purified dihydrofolate reductase from mammalian sources.
    Coward JK; Parameswaran KN; Cashmore AR; Bertino JR
    Biochemistry; 1974 Sep; 13(19):3899-903. PubMed ID: 4528865
    [No Abstract]   [Full Text] [Related]  

  • 17. Role of the cellular oxidation-reduction state in methotrexate binding to dihydrofolate reductase and dissociation induced by reduced folates.
    Matherly LH; Anderson LA; Goldman ID
    Cancer Res; 1984 Jun; 44(6):2325-30. PubMed ID: 6609765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of methotrexate esters and other lipophilic antifolates on methotrexate-resistant human leukemic lymphoblasts.
    Rosowsky A; Lazarus H; Yuan GC; Beltz WR; Mangini L; Abelson HT; Modest EJ; Frei E
    Biochem Pharmacol; 1980 Feb; 29(4):648-52. PubMed ID: 6929188
    [No Abstract]   [Full Text] [Related]  

  • 19. Antifolate polyglutamylation and competitive drug displacement at dihydrofolate reductase as important elements in leucovorin rescue in L1210 cells.
    Matherly LH; Barlowe CK; Goldman ID
    Cancer Res; 1986 Feb; 46(2):588-93. PubMed ID: 2416428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Further studies on substituted quinazolines and triazines as inhibitors of a methotrexate-insensitive murine dihydrofolate reductase.
    Dedhar S; Freisheim JH; Hynes JB; Goldie JH
    Biochem Pharmacol; 1986 Apr; 35(7):1143-7. PubMed ID: 3964294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.